FDA Investigator Franklin D Heisler
Franklin D Heisler has conducted inspections on 26 sites in 1 countries as of 07 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
26
Last Inspection Date:
07 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Franklin D Heisler:
Aaron L Dunbar,
Adree N Anderson,
Alesya V Oleynik,
Alysia C Alger,
Andrew A Hoopes,
Andrew K Schaal,
Andrew M Kolenc,
Anna J Vickrey,
Anna L Tucker,
Aqualia L Nelson,
Avery J Dennis,
Babatunde Ojo,
Bei Y He,
Blake R Jensen,
Brent T Hall,
Brent W Higgs,
Brian L Szcyubialka,
Charles L Zhou,
Christin L Torres,
Christopher D Snyder,
Clinton K George,
Consuelo E Nausin,
Dana D Carter, SR DDS,
Darrah,
Darren D Holaday,
David A Lum,
David L Miser,
Diana K Krepel,
Diane T Reindl,
Dina K West,
Edna J Hidalgo,
Elias H Wachter,
Elvin R Smith,
Emilie E Kahn,
Emily J Orban,
Eric C Nielsen,
Eric M Mueller, PharmD,
Eric T Huebler,
Fred K Kelly,
Frederick J Tillman,
Garrett W Steiner,
Heath W Cartwright,
Holly L Miller,
Huffmanc,
Jacob G Lutz,
Janete A Oliveira,
Jeffrey D Meng,
Jessie E Morris,
Jocelyn T Ramos,
Johnson,
Jon C Polzine,
Joseph A Piechocki,
Kamara Co,
Karen M Labounty,
Katherine M Taylor,
Kathleen J Close,
Kellia N Hicks,
Kevin L Torgerson,
LCDR Matthew J Morrison,
Linda S Shook,
Linhart,
Lori A Gioia,
Louis S Chen,
Marion W Nadeau,
Mark I Nakano,
Matthew J Hansen,
Meisha Waters,
Melinda L Rice,
Melva J Palmer,
Naseem S Jouhari,
Neira Acevedo Ramos,
Ngoc B Kelsch,
Nia K Walker,
Nicole Yuen,
Paul Klug,
Peng Zhou,
Peter E Gruman,
Ponzoj,
Rebecca S Secrist,
Ricki A Chase,
Ryan S Martin,
Sabino S Camacho,
Samuel K Gibbons, Jr,
Sandra D Wilson,
Sarah A Palmer,
Sarah M Meng,
Sarah M Napier,
Scot M Stodola,
Scott A Jepson,
Secrist,
Steven C Himebaugh,
Steven P Allen,
Stroman,
Terrence Gee,
Thomas S Donaldson,
Tristian E Strait,
Tyson J Eldridge Stedman,
Walsworth,
Wayne D Mcgrath,
William J Weis,
Zachary A Bogorad
Franklin D Heisler's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2021 | EIR | Zoetis LLC - EIR, 2021-05-03 |
May, 2021 | FDA 483 Response | Zoetis LLC - Form 483R, 2021-05-24 |
October, 2019 | EIR | Marzetti Frozen Pasta, Inc. - EIR, 2019-10-08 |
May, 2021 | FDA 483 | Zoetis LLC - Form 483, 2021-05-03 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more